Fractyl's Type 2 diabetes device study shows HbA1c benefits sustained for 2 years

Authors :: Hale, Conor
Source :: Fiercebiotech.com. February 2, 2022
Publication Year :: 2022
Abstract: Byline: Conor Hale A study of Fractyl Health's one-time procedure for rejuvenating the lining of the intestines demonstrated significant and durable gains in blood sugar control for up to two [...]

Subjects :: Medical research -- Reports
Medicine, Experimental -- Reports
Diabetes therapy -- Reports -- Research
Glycosylated hemoglobin -- Research -- Reports
Blood sugar -- Reports -- Research
Type 2 diabetes -- Care and treatment -- Research
Biotechnology industry

Tools